Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108129308A introduces visible light catalysis for ester synthesis offering green supply chain and cost advantages for pharmaceutical intermediate manufacturing processes globally.
Novel photoredox catalysis route for Obitavir reduces steps and metal use. Enhances supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN107353245B reveals metal-free photocatalytic route. Delivers high purity quinoline intermediates with significant supply chain and cost advantages for global buyers.
Novel visible-light mediated method for 1,1-diarylalkanes. High yield, mild conditions. Ideal for pharmaceutical intermediate manufacturing and supply chain optimization.
Discover a green, visible-light mediated method for synthesizing phosphorylated quinazolinone compounds. This novel route offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel photocatalytic carbene route for high-purity intermediates. Reduces steps and enhances supply chain reliability for global pharmaceutical and polymer manufacturers seeking cost reduction.
Patent CN117924125B details metal-free visible light synthesis for sulfonamide derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105503742A reveals visible light photocatalysis for high-yield difluoroalkyl uracil synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN111217736A reveals a mild visible-light method for 2-acylindoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112390696B reveals a safe, metal-free method for alpha-aminonitrile synthesis using benzoyl cyanide and visible light, offering significant cost and safety advantages.
Novel photocatalytic method using acetone eliminates expensive metals. Ideal for API intermediates manufacturing with reduced costs and simplified supply chains.
Patent CN111253254A details a green CuCl2-catalyzed dichlorination method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN111253254B details a mild visible light method for dichloride synthesis using CuCl2. This offers cost reduction in fine chemical manufacturing and reliable supply.
Patent CN108409764A reveals nickel synergistic BODIPY catalysts. Enables cost-effective C-X bond formation. Reliable supply for pharma intermediates.
Novel photocatalytic synthesis route for high-purity phenanthridine derivatives. Green chemistry approach ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Patent CN115010563B reveals a green nickel-catalyzed halogen exchange method. This technology offers cost reduction in pharmaceutical intermediate manufacturing via mild visible light conditions.
Patent CN116396209B reveals a green photocatalytic route for alkyl perfluoroalkyl ketones. Discover cost-effective manufacturing and high-purity supply chain solutions.